CXCL8 and ovarian neoplasm: To study the feasibility of the combination of oncolytic adenovirus and IL-8 blocking antibody, we tested the cell killing abilities of the combination in an MTS cell viability assay using single cell suspensions from human ovarian tumors samples (Figure 5).